Literature DB >> 32133623

Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation.

Mitchell S Cairo1,2,3,4,5, Kenneth R Cooke6, Hillard M Lazarus7, Nelson Chao8,9,10.   

Abstract

Sinusoidal obstruction syndrome (SOS), previously known as hepatic veno-occlusive disease (VOD), remains a multi-organ system complication following haematopoietic cell transplantation (HCT). When SOS/VOD is accompanied by multi-organ dysfunction, overall mortality rates remain >80%. However, the definitions related to the diagnosis and grading of SOS/VOD after HCT are almost 25 years old and require new and contemporary modifications. Importantly, the pathophysiology of SOS/VOD, including the contribution of dysregulated inflammatory and coagulation cascades as well as the critical importance of liver and vascular derived endothelial dysfunction, have been elucidated. Here we summarise new information on pathogenesis of SOS/VOD; identify modifiable and unmodifiable risk factors for disease development; propose novel, contemporary and panel opinion-based diagnostic criteria and an innovative organ-based method of SOS/VOD grading classification; and review current approaches for prophylaxis and treatment of SOS/VOD. This review will hopefully illuminate pathways responsible for drug-induced liver injury and manifestations of disease, sharpen awareness of risk for disease development and enhance the timely and correct diagnosis of SOS/VOD post-HCT.
© 2020 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Keywords:  definitions; grading; haematopoietic cell transplantation; sinusoidal obstruction syndrome; veno-occlusive disease

Year:  2020        PMID: 32133623      PMCID: PMC7483983          DOI: 10.1111/bjh.16557

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  100 in total

Review 1.  Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome.

Authors:  Paul G Richardson; Brandon M Triplett; Vincent T Ho; Nelson Chao; Fiona L Dignan; Michelle Maglio; Mohamad Mohty
Journal:  Expert Rev Clin Pharmacol       Date:  2018-01-05       Impact factor: 5.045

2.  Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation.

Authors:  Ayman Akil; Qing Zhang; Christen L Mumaw; Nisha Raiker; Jeffrey Yu; Nieves Velez de Mendizabal; Laura S Haneline; Kent A Robertson; Jodi Skiles; Maribel Diaz-Ricart; Enric Carreras; Jamie Renbarger; Samir Hanash; Robert R Bies; Sophie Paczesny
Journal:  Biol Blood Marrow Transplant       Date:  2015-07-11       Impact factor: 5.742

3.  Clinical diagnosis of veno-occlusive disease using contrast enhanced ultrasound.

Authors:  C Trenker; K Sohlbach; C F Dietrich; C Görg
Journal:  Bone Marrow Transplant       Date:  2018-05-22       Impact factor: 5.483

Review 4.  Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.

Authors:  Selim Corbacioglu; Elias J Jabbour; Mohamad Mohty
Journal:  Biol Blood Marrow Transplant       Date:  2019-02-22       Impact factor: 5.742

Review 5.  Use of defibrotide in the treatment and prevention of veno-occlusive disease.

Authors:  Paul Richardson; Erica Linden; Carolyn Revta; Vincent Ho
Journal:  Expert Rev Hematol       Date:  2009-08       Impact factor: 2.929

6.  Veno-occlusive disease of the liver after high-dose mitomycin C therapy and autologous bone marrow transplantation.

Authors:  H M Lazarus; M R Gottfried; R H Herzig; G L Phillips; R S Weiner; G P Sarna; J Fay; S N Wolff; O Sudilovsky; R P Gale; G P Herzig
Journal:  Cancer       Date:  1982-05-01       Impact factor: 6.860

7.  Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.

Authors:  Minoru Ando; Kazuteru Ohashi; Hideki Akiyama; Hisashi Sakamaki; Taku Morito; Ken Tsuchiya; Kosaku Nitta
Journal:  Nephrol Dial Transplant       Date:  2009-09-17       Impact factor: 5.992

8.  BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.

Authors:  Fiona L Dignan; Robert F Wynn; Nedim Hadzic; John Karani; Alberto Quaglia; Antonio Pagliuca; Paul Veys; Michael N Potter
Journal:  Br J Haematol       Date:  2013-09-17       Impact factor: 6.998

Review 9.  Liver sinusoidal endothelial cells: Physiology and role in liver diseases.

Authors:  Johanne Poisson; Sara Lemoinne; Chantal Boulanger; François Durand; Richard Moreau; Dominique Valla; Pierre-Emmanuel Rautou
Journal:  J Hepatol       Date:  2016-07-14       Impact factor: 25.083

10.  Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome.

Authors:  Nancy A Kernan; Stephan Grupp; Angela R Smith; Sally Arai; Brandon Triplett; Joseph H Antin; Leslie Lehmann; Tsiporah Shore; Vincent T Ho; Nancy Bunin; Massimo Iacobelli; Wei Liang; Robin Hume; William Tappe; Robert Soiffer; Paul Richardson
Journal:  Br J Haematol       Date:  2018-05-16       Impact factor: 6.998

View more
  7 in total

Review 1.  Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy.

Authors:  Filippo Milano; Joshua A Hill; Lorenzo Iovino; Laurel A Thur; Sacha Gnjatic; Aude Chapuis
Journal:  J Immunother Cancer       Date:  2021-05       Impact factor: 13.751

2.  Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome.

Authors:  Yongrong Lai; Qiaochuan Li; Xiaoxuan Lai; Lianjin Liu; Zhongming Zhang; Lingling Shi; Gaohui Yang; Meiqing Wu; Rui Huang; Rongrong Liu
Journal:  Bone Marrow Transplant       Date:  2021-02-19       Impact factor: 5.483

3.  Challenges to be addressed in management of patients with sinusoidal obstruction syndrome after hematopoietic cell transplantation.

Authors:  Seong Kyu Park; Young Sok Ji; Se Hyung Kim
Journal:  Korean J Intern Med       Date:  2021-12-29       Impact factor: 2.884

4.  Incidence and Risk Factors for Acute Kidney Injury after Allogeneic Stem Cell Transplantation: A Prospective Study.

Authors:  Andreea Andronesi; Bogdan Sorohan; Andreea Burcea; Lavinia Lipan; Cristina Stanescu; Oana Craciun; Laura Stefan; Adela Ranete; Zsofia Varady; Oana Ungureanu; Gabriela Lupusoru; Gabriela Agrigoroaei; Danut Andronesi; Luminita Iliuta; Bogdan Obrisca; Alina Tanase
Journal:  Biomedicines       Date:  2022-01-25

5.  A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation.

Authors:  Shannon Robin; Khalil Ben Hassine; Tiago Nava; Chakradhara Rao S Uppugunduri; Marc Ansari; Jayaraman Muthukumaran; Simona Jurkovic Mlakar; Maja Krajinovic
Journal:  BMC Mol Cell Biol       Date:  2022-01-21

6.  [Advances in the diagnosis and management of sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation].

Authors:  X Cai; X H Zhang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-12-14

7.  Analysis of risk factors for hepatic sinusoidal obstruction syndrome following allogeneic hematopoietic stem cell transplantation in pediatric patients.

Authors:  Jaspar Kloehn; Grit Brodt; Jana Ernst; Bernd Gruhn
Journal:  J Cancer Res Clin Oncol       Date:  2021-07-13       Impact factor: 4.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.